Table 2.
Characteristic | n(%) |
---|---|
Planning studies | |
CT only | 12 (86) |
PET | 1 (7) |
MRI | 2 (14) |
Tumor volume, cm3 | |
Mean | 120.9 |
Median | 99.7 |
Range | 21–225 |
Prescribed dose, Gy | |
Mean | 28.8 |
Median | 28.5 |
Range | 16–42 |
Number of fractions | |
Median | 3 |
Range | 2–5 |
Median dose per fraction | 8.3 Gy |
Treatment duration (days) | |
Median | 3 |
Range | 1–13 |
BED10, Gy | |
Mean | 55.1 |
Median | 49.7 |
Range | 28–100.8 |
Prescription isodose line, % | |
Mean | 74.6 |
Median | 75 |
Range | 65–90 |
Conformality index | |
Mean | 1.7 |
Median | 1.7 |
Range | 1.2–2.54 |